David Erickson | Vice President of Investor Relations |
David Moatazedi | President and Chief Executive Officer |
Rui Avelar | Chief Medical Officer and Head of Research and Development |
Sandra Beaver | Chief Financial Officer |
Annabel Samimy | Stifel, Nicolaus & Company, Inc. |
Marc Goodman | SVB Securities |
Douglas Tsao | H.C. Wainwright & Co. |
Louise Chen | Cantor Fitzgerald & Co. |
Navann Ty | BNP Paribas Exane |
Serge Belanger | Needham & Company, LLC |
Gregory Fraser | Truist Securities, Inc. |
Uy Ear | Mizuho Securities Co. |
Greetings, and welcome to the Evolus Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, David Erickson, Vice President, Investor Relations.